Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
The current studies further investigated the effects, in animal models of anxiety, of novel putative anxiolytic and anxiogenic compounds believed to induce their effects by actions at the GABA-benzodiazepine receptor complex. It was expected that the results would also provide further validation for a novel test of anxiety based on the ratio of open to closed arm entries in an elevated plus maze in the rat. The novel putative anxiolytics CL 218,872 (10-20 mg/kg) and tracazolate (5 mg/kg) significantly elevated the percentage of time spent on the open arms of an elevated plus-maze, consistent with their anxiolytic activity in several other animal tests. Also consistent with results from other animal tests, no anxiolytic activity was observed for the phenylquinoline PK 8165 (10-25 mg/kg), the 3,4-benzodiazepine tofisopam (25-50 mg/kg), or buspirone (0.5-20 mg/kg). The benzodiazepine receptor inverse agonists FG 7142 (1-5 mg/kg) and CGS 8216 (3-10 mg/kg) had anxiogenic activity in this test, as did the atypical benzodiazepine Ro 5-4864 (1-5 mg/kg). Interestingly, however, the benzodiazepine receptor antagonists Ro 15-1788 (10-20 mg/kg) and ZK 93426 (5-10 mg/kg) had no anxiogenic activity in this test.
Pellow
S
S
File
S E
SE
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001007:Anxiety / Q000139:chemically induced / Q000503:physiopathology*; D001569:Benzodiazepines / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology; D002065:Buspirone; D002243:Carbolines / Q000494:pharmacology; D003292:Convulsants / Q000494:pharmacology; D005106:Exploratory Behavior / Q000187:drug effects*; D005442:Flumazenil; D008297:Male; D011720:Pyrazoles / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D051381:Rats
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D002243:Carbolines; D003292:Convulsants; D011720:Pyrazoles; D011724:Pyridazines; D011743:Pyrimidines; D011804:Quinolines; D001569:Benzodiazepines; C028513:4'-chlorodiazepam; D005442:Flumazenil; C035874:FG 7142; C021604:CL 218872; C033830:2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one; C042568:ZK 93426; C030078:pipequaline; C034317:tracazolate; D002065:Buspirone; C012582:tofisopam